You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (8)

Journals (0)

1-8 of 8 results for aduhelm

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data

Retricted access

Article commentary

First published 2021-12-07

Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data

Poul F. Høilund-Carlsen, Abass Alavi

Journal of Alzheimer’s Disease

Select article: StockWatch: Investors Unfazed by Biogen CEO Search,Aduhelm Cutbacks

Retricted access

Research article

First published 2022-5

StockWatch: Investors Unfazed by Biogen CEO Search,Aduhelm Cutbacks

Alex Philippidis

GEN Edge

Select article: StockWatch: Biogen Stays Flat Despite Positive 128-Week Aduhelm Data

Retricted access

Research article

First published 2022-3

StockWatch: Biogen Stays Flat Despite Positive 128-Week Aduhelm Data

Alex Philippidis

GEN Edge

Select article: Aduhelm: The Best Hope for Alzheimer’s Disease Patients or the Worst Decision the FDA Has Ever Made?

Free access

Editorial

First published 2021-11-23

Aduhelm: The Best Hope for Alzheimer’s Disease Patients or the Worst Decision the FDA Has Ever Made?

Markku Kurkinen, Lloyd Tran

Journal of Alzheimer’s Disease

Select article: Green Light Raises Red Flags: FDA,some experts at odds over agency's accelerated approval for Aduhelm,the Alzheimer's disease drug from Biogen and Eisai

Retricted access

Research article

First published 2021-7

Green Light Raises Red Flags: FDA,some experts at odds over agency's accelerated approval for Aduhelm,the Alzheimer's disease drug from Biogen and Eisai

Alex Philippidis

Inside Precision Medicine

Select article: Making the Case for the Accelerated Withdrawal of Aducanumab

Retricted access

Article commentary

First published 2022-05-31

Making the Case for the Accelerated Withdrawal of Aducanumab

Peter J. Whitehouse, Vikas Saini

Journal of Alzheimer’s Disease

Select article: Making the Case for Accelerated Withdrawal of Aducanumab

Free access

Meeting report

First published 2022-05-31

Making the Case for Accelerated Withdrawal of Aducanumab

Peter Whitehouse, Sam Gandy, Vikas Saini [...]

Journal of Alzheimer’s Disease

Select article: Alzheimer’s and Dementia Research Coverage in News Media Outlets Consumed by Population Groups that Are Underrepresented on Alzheimer’s and Dementia-Focused Research Registries

Retricted access

Research article

First published 2026-4

Alzheimer’s and Dementia Research Coverage in News Media Outlets Consumed by Population Groups that Are Underrepresented on Alzheimer’s and Dementia-Focused Research Registries

Erin K. Maloney, Amy Bleakley, Allie J. White

Research on Aging

1
10 / page

Article type

Publication date

Subjects

Access